ARCpoint

ARCpoint CROIC

The Cash Return on Invested Capital (CROIC) of ARCpoint (ARC.V) as of Oct 24, 2026 is 20.37 %. In the previous year, Cash Return on Invested Capital (CROIC) was 49.01 % — a change of -58.44% (lower).

CROIC

20.37 %

YoY

-58.44%

Last updated:

Cash Return on Invested Capital (CROIC) of ARCpoint is 2025 20.37 % . Cash Return on Invested Capital (CROIC) of ARCpoint was 2024 49.01 % . It decreases by -58.44% lower compared to the previous year.

The ARCpoint CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2021
137.93 USD
Jan 1, 2022
-64.09 USD
Jan 1, 2023
59.08 USD
Jan 1, 2024
49.01 USD
Jan 1, 2025
20.37 USD
The ARCpoint CROIC history
YEARCROICYoY
20.37 %-58.44%
49.01 %-17.03%
59.08 %-192.18%
-64.09 %-146.46%
137.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ARCpoint Stock analysis

What does ARCpoint do? ARCpoint, Inc. generates revenue through its franchise system, which includes drug testing, alcohol screening, DNA, and clinical lab testing services. The ARCpoint Franchise segment sells franchises to individuals across the United States, providing marketing, technology, and training support. The AFG Services segment offers clinical testing, software services, and diagnostic testing kits to franchisees and other business-to-business customers. The Other segment operates corporate-owned labs that serve businesses, physicians, and customers directly. Revenue streams include franchise fees, sales of diagnostic kits, and corporate lab services. ARCpoint Franchise segment revenue comes from franchise sales and ongoing support services. AFG Services segment revenue is derived from clinical testing, software services, and direct sales of diagnostic kits to business customers. Corporate-owned labs in the Other segment provide clinical and diagnostic services to businesses, physicians, and end customers, contributing to overall revenue. The company's business model relies on a mix of franchise sales, service offerings, and direct B2B transactions. The company's primary customers are individuals purchasing franchises, businesses requiring clinical testing, and physicians seeking diagnostic services. Franchisees benefit from ARCpoint's marketing, technology, and training support. AFG Services targets businesses needing diagnostic kits and software solutions. Corporate-owned labs serve businesses, physicians, and end customers with comprehensive testing solutions. Revenue is generated through multiple channels within the company's segmented structure. ARCpoint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ARCpoint stock

Cash Return on Invested Capital (CROIC) of ARCpoint is 20.37 % in 2025.

Cash Return on Invested Capital (CROIC) of ARCpoint changed from 49.01 % to 20.37 %, representing a -58.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) ARCpoint since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s ARCpoint with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ARCpoint

All Key Metrics — ARCpoint